NAGE
Niagen Bioscience Inc
NASDAQ · Healthcare · Biotechnology · US
$3.17
+1.93%Forward multiples
Based on analyst estimates
- P/E forward
- 25.77x
- P/E 2026E
- 21.74x
- P/E 2027E
- 20.23x
- P/E 2028E
- 12.54x
- P/S forward
- 1.72x
Trailing multiples
Trailing twelve months
- P/E TTM
- 16.32x
- PEG TTM
- —
- Price / book
- 3.04x
- Price / sales
- 1.94x
- Price / cash flow
- 42.16x
Enterprise value
- Enterprise value
- $186.4M
- EV / sales
- 1.44x
- EV / EBITDA
- 10.09x
- EV / EBIT
- 21.64x
- Market cap
- $250.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026